Official announcements
Recall
|
Medicines
|
27/06/2025
Recall due to a mix-up with another product
Recall
|
Medicines
|
26/06/2025
Recall due to nitrosamine contamination above the permitted daily dose
Recall
|
Medicines
|
26/06/2025
Recall of the pharmaceutical samples of the mentioned batches due to exceeding the remaining shelf life
Safety warnings
|
Medical devices
|
26/06/2025
The products of the manufacturer "Allergan Aesthetics", a company of AbbVie, are facial fillers that are used in aesthetic medicine to treat wrinkles and to change the appearance of the face.
Recall
|
Medicines
|
24/06/2025
Recall of due to reduced efficacy
messages in brief
|
17/06/2025
To better monitor and, if necessary, counteract supply shortages of medicinal products at EU level, the European Shortages Monitoring Platform (ESMP) was established by the EMA in accordance with the Regulation (EU) 2022/123. The full version of the platform was launched in January 2025.
Safety warnings
|
Blood & Tissue
|
06/06/2025
The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that 2 offspring of the sperm donor 8860 RUMLE have been diagnosed with DiGeorge syndrome (22q11 deletion syndrome).
The donor/gametes were permanently blocked.
CHMP Monthly News
|
04/06/2025
Up-to-date information from the 19.05.-22.05.2025 meeting on new approvals, extensions of indication, newly published EPAR's and recently started procedures.
messages in brief
|
03/06/2025
Austria is sending a clear signal in favour of research-friendly framework conditions.
For clinical trials in accordance with Regulation (EU) No. 536/20214 that are conducted exclusively in Austria, EU-wide coordination is no longer required. The new procedure significantly shortens the authorisation period.